Skip to main content
Login
Contact
Subscribe
Search form
Search
The Evening Leader?
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Classified Display Ads
Service Directory
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Denali Therapeutics Inc
(NQ:
DNLI
)
24.65
USD
-0.25 (-1.00%)
Official Closing Price
/ Updated:
5:59 PM EST, Jan 24, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
937,800
Open
25.00
Bid (Size)
21.61 (1)
Ask (Size)
25.50 (1)
Prev. Close
24.90
Today's Range
24.22 - 25.43
52wk Range
14.24 - 28.86
Shares Outstanding
94,441,892
Dividend Yield
N/A
Performance
YTD
+50.40%
+50.40%
1 Month
+29.46%
+29.46%
3 Month
+57.11%
+57.11%
6 Month
+16.66%
+16.66%
1 Year
+12.81%
+12.81%
Top News
More News
Denali Therapeutics Announces Broad Pipeline Progress Including Positive Results From Its LRRK2 Program for Parkinson’s Disease
January 14, 2020
from
GlobeNewswire News Releases
Flagship Unveils Newest Pioneering Platform: Ring Therapeutics
December 19, 2019
New Company Is First to Harness the Human Commensal Virome for the Development of Novel DNA and Gene Therapies
Read More
from
PR Newswire
More News
Read More
Flagship Pioneering Strengthens Leadership With Appointment of Paul Biondi as Executive Partner
December 16, 2019
from
PR Newswire
Flagship Pioneering Unveils Cellarity, the First Company to Discover Medicines Targeting Cell Behavior
December 10, 2019
from
PR Newswire
Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award
December 02, 2019
from
PR Newswire
Torque Presents Preclinical Data for Lead Deep-Primed Cellular Immunotherapy Programs at AACR 2019 Special Conference on Tumor Immunology and Immunotherapy
November 19, 2019
from
PR Newswire
First Week of September 18th Options Trading For Denali Therapeutics (DNLI)
January 23, 2020
category
Stocks
from
Market News Video
Flagship Pioneering Appoints Prakash Raman, Ph.D. as Senior Partner and Chief Business Development Officer
November 12, 2019
from
PR Newswire
Tuesday's ETF Movers: XBI, CQQQ
January 14, 2020
category
ETFs
from
ETF Channel
Stock Charts To Watch - Tuesday, Jan. 14
January 15, 2020
category
Stocks / Equities
from
Blogs - TalkMarkets
Bullish Two Hundred Day Moving Average Cross - DNLI
January 14, 2020
category
Stocks
from
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
X
Username
*
Password
*
Request new password
